chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Began a menstrual cycle 2 days after first vaccine that never stopped. After 2nd dose vaccine bleeding became uncontrollable, hemoraging with massive clots. Unlike any bleeding or cycle I had ever experienced in my life. No medication would resolve the issue. After 110 days of a extreme, non-stop menstrual cycle I had an endometrial ablation. Nothing was found in my endometrial lining to explain the bleeding. The only cause was the vaccine. I was anemic given the months of bleeding, I had consistent headaches, fatigue, and an eye  twitch that developed on the left hand side.  Given that my only choice to stop the bleeding was to have a surgical procedure, I am now no longer able to have children after taking the vaccine.
At 7 pm on evening after vaccination, had seizure, brief, with 1-hour post-ictal period. Child has known seizure disorder and takes an anticonvulsant medication - KEPPRA.
had classic symptoms after the second dose/fever and body aches; had classic symptoms after the second dose/fever and body aches; the vaccine she received has been deemed invalid due to record keeping practice and temperature.; the vaccine she received has been deemed invalid due to record keeping practice and temperature.; This is a spontaneous report from a contactable consumer (patient). A 56-years-old female patient received second dose of bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EW0153), via an unspecified route of administration, administered in Arm Left on 08Apr2021 09:00 (Age at Time of Vaccination 56 Years) as single dose for COVID-19 immunisation. The medical history was none. Concomitant medication included vitamins nos. Historical vaccine includes first dose of bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EP6955), dose 1 via an unspecified route of administration, administered in Arm Left 19Mar2021 09:00 as single dose for COVID-19 immunisation. No prior vaccinations within 4 weeks. On Apr2021 the patient experienced the vaccine she received has been deemed invalid due to record keeping practice and temperature, on 09Apr2021 had classic symptoms after the second dose/fever and body aches. No emergency Room or Physician Office. No relevant Tests done. She was already received advice from her doctor to get an antibody test, She reached out on her own to the owner of the clinic and was told that the owner felt the caller did get the vaccine. It is explained that she wants to fly to withheld in August but that government is very strict and she will have to show proof vaccination. When she went online it does, in fact say, her vaccine is invalid. She spoke to a doctor who encouraged her to get antibody test, which she has scheduled on Friday. The caller is nervous about doing a repeat of the vaccine. If the antibodies are positive she doesn't want to get the vaccine again as she is worried it will cause her body to react in a way. This was heard through a friend, that the place had been shut down, on the news. A week after the second dose she reached out to the department of health who finally called her back and explained it was true and that about 7000 people were affected and they should redo the vaccines, get both doses again. They couldn't provide any medical information which really upset her regarding this situation. Caller has no information or product details for the 7000 mentioned during this report but explains it was all on the news. The outcome for even the vaccine she received has been deemed invalid due to record keeping practice and temperature was not recovered, other events was recovered on 10Apr2021.
VACCINE ADMINISTERED AT 10:19, AT 10:22 PT C/O DIZZINESS AND REPORTED NUMBNESS AND TINGLING IN BOTH EXTREMITIES. PT WAS GUIDED TO  A FLAT SURFACE IN A SUPINE POSITION WITH LEGS RAISED UP ON THE CHAIR. COLD ICE PACK WAS APPLIED  AT THE BACKOF HIS NECK,  SLOW DEEP BREATHS ENCOURAGED. VITALS INCLUDED; 108/68, 74BPM,  RR=16.  AT 10:27  AM PT REPORTED SYMPTOMS HAD SUBSIDED.  PT WAS OBSERVED FOR 20 MORE MINUTES AND D/C WITH NO MORE SYMPTOMS OBSERVED OR REPORTED.
2 days p/vax broke out in bright red rash over entire body w/fever of 101; lasted 3 days seen by  pediatrician & diagnosed viral exanthem;
This spontaneous report was received from a healthcare worker referring to a 9 week old patient of unknown gender. The patients' concurrent conditions and medical histories were not provided. On 26-OCT-2015, the patient was vaccinated with a dose of improperly stored ROTATEQ orally (dose was unknown, lot # K023532, expiration date 21-JUN-2016). Concomitant medication was not reported. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Extreme sudden fatigue, itchy lower eyelids, eyes feel warm when closed, chills, and goosebumps
Stomachache, loose stools, chills for about 24 hours.   Tuesday 2/5/21 developed hives on face.   Stomach issues improved. Still have hives, took Benadryl last night, will repeat tonight.
I broke out with a rash which started on my legs and spread all over my body except my face. I had large red welts, not hives, and it itched and felt like skin was crawling.
4OCT96 recv vax & 4OCT96 3PM called MD pt fussy w/nausea & vomiting;5-6PM fever? mom had been giving APAP all day;5OCT96 1230AM convuls taken to hosp;7OCT96 t102.6;
This spontaneous report as received from a Registered Nurse refers to a female patient of unknown age. On an unspecified date, the patient was vaccinated with the full series of RECOMBIVAX HB doses (Lot #, dose and route not reported). No other co-suspects were reported. No concomitant medications were reported. It was reported that on an unknown date, the patient had a negative titer for hepatitis B antibodies. Blood test were performed (results not provided). No treatment was given for the event. The status of the patient had not changed since the titer. The relatedness for negative titer for hepatitis B antibodies was unknown unknown for RECOMBIVAX HB. This is one of two reports received from the same source. Additional information has been requested.
Pt mistakenly administered two doses of Fluzone HD at same visit in addition to COVID booster (SPIKEVAX).  No adverse effect reported as of 10/13/2023 7:10pm
10/21/11 Flu shot given. 10/22/11 Sore body, sore throat. 10/23/11 Rash and hives neck, chest, arms, hands. Chest pains, hard to breathe. 10/24 11 Went to Allergist. Did blood wk - all negative. Gave me Lidocaine viscous. Called today Allergist. General sore throat and rash.
This spontaneous report as received from a nurse refers to 57 patients of unknown age and gender. On an unknown date the patients were vaccinated with RECOMBIVAX HB (dose and lot number were unknown) which was improperly stored. No adverse events were reported. The outcome of the event was unknown. No further information was provided. This case is linked to (MARRS # 1411USA009917, 1411USA004296, 1411USA009915, 1411USA009916) with the same reporter link. Additional information has been requested.
Intestinal cramps, chills, lethargy, headache lasting 24 hours.
Atrial Fibrillation starting suddenly about 1 month after the second Pfizer vaccination for Covid19.  Possibly caused or linked in some way to the vaccine?  My wife is now on Eliquis and other drugs to control fast and irregular heartbeat.
Chest pain two days after vaccine.  Of note, patient had COVID infection in March 2020.
pt recvd vax 22OCT92 & exp tenderness in the rt lower chest; By that evening pt sx subsided; pt recvd 2nd & 3rd dose of vax 2DEC92 & 21APR93, respectively;
No adverse symptoms; The patient recieved adult and pedriatic doses of VAQTA; This spontaneous report was received from the physician regarding a 14-year-old male patient. The patient's concurrent conditions and medical history, as well as concomitant medications, were not reported.  On 01-JUL-2015, the patient received an adult dose of Hepatitis A Vaccine, Inactivated (VAQTA) (strength 50/1 units per milliliter (U/ml)) and on 28-AUG-2015, she received a pediatric dose of Hepatitis A Vaccine, Inactivated (VAQTA) (strength 25/0.5 U/ml) (lot# and expiration date for both vaccines were unknown); The physician stated that on 12-JUN-2020, the patient who was 19-year-old, received a pediatric dose of  Hepatitis A Vaccine, Inactivated (VAQTA) (strength 25/0.5 U/ml) (Lot# S037574, expiration date 10-APR-2021). All vaccines were given for prophylaxis (dose, route and anatomical site of administration and vaccination schedule for all vaccines were not provided). No adverse symptoms were reported.  combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; devicelotnumber: S037574; expirationdate: 10-APR-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
3 HOURS AFTER THE INJECTION, PATIENT STARTED FEELING "BAD" OVERALL. ARM HURT AND MUSCLE SORENESS. PATIENT REPORTED FEELING DYSPHORIA. THIS FEELING LASTED ABOUT 3 DAYS. THE SECOND DAY WAS THE WORST. NO VOMITING, NO FEVER. JUST WANTED TO SIT OR LAY DOWN ALL DAY. PATIENT EXPERIENCED SHARP PAIN IN THE RIB CAGE ON RIGHT SIDE (SAME SIDE AS INJECTION) FROM DAYS 3-6 POST INJECTION. THEN BACK TO NORMAL.
She broke in a crazy rash; Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (non-serious) with onset 2021, outcome "unknown", described as "Booster"; RASH (non-serious), outcome "not recovered", described as "She broke in a crazy rash". Clinical course: This report is not related to a study or programme. Reporter does not know the patient personally. Reporter is a Pharmacy Technician. Caller stated that she has a girlfriend, who has a neighbour across the street that got the booster, and she broke in a crazy rash which went away but then would come back on a Monday go away Tuesday, come back Wednesday, and this happened for months. When probed for the Lot and Expiry date of the Covid Booster for this neighbour's experience, caller stated that she doesn't know her, it's her friends neighbour, she did not have a lot or expiry.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Arm pain X 2 weeks, post vax, especially with swimming. Pain only with overhead use of arm, localized to exertion of the deltoid.
6cm X 5 cm oval shaped contusion (RED/ TENDER) with headaches and shoulder blade Px
pt recv vax & exp soreness & heat @ the inj site, devel redness @ the inj site & exp muscles aches to point could not lift arms;
tongue stiffness, tingling, skin tingling, lymphadenopathy, muscle stiffness
Unfortunately that facility has recently had an outbreak of COVID, and he was found to be positive on Friday 04/29/2022.  He had been largely asymptomatic until yesterday
This spontaneous report (initial receipt: 08-OCT-2014) concerns a 14-year-old male patient. On 05-OCT-2014, the patient received AFLURIA (batch number not reported). On an unspecified date after vaccination, the patient's arm was more swollen than usual at the injection site. The patient may have been allergy to one of AFLURIA's ingredients. Outcome was not reported.
06/22/17- Present fever and redness/pain in upper left arm where vaccine was administered. 06/23/17 - Z-PAK 06/24/17 - KEFLEX 06/25/17 - KEFLEX (increased dose) and BACTRIM DS.
Cellulitis (horrific reaction); Arm still flares; This case was reported by a consumer via interactive digital media and described the occurrence of cellulitis in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced cellulitis (serious criteria GSK medically significant) and burning sensation. On an unknown date, the outcome of the cellulitis was unknown and the outcome of the burning sensation was not recovered/not resolved.   It was unknown if the reporter considered the cellulitis and burning sensation to be related to Shingrix.     Additional Information: GSK Receipt Date: 25-Sep-2022 Reporter's comment: This case was reported by the patient via interactive digital media. The patient had a horrific reaction which had turned into Cellulitis from the reaction.   The patient's arm still had flares. The patient remembered when his/her friends had shingles. The pain and suffering they went through it sounded unbearable. They never wanted to experience that kind of pain, which had made the patient who wanted to learn more about this painful, blistering rash. The patient educated himself about the risk for developing shingles, especially for people 50 years or older, and what the patient could do for prevention. The patient had taken action. The patient wanted to find out more about the risk of shingles and take steps to help and prevent this painful rash. The reporter did not agreed that the company's safety team who may contact their Healthcare professional to gather information. The permission for consent to follow-up was denied.
Patient infornmed me of possibility of fainting after injection of vaccine. Patient reported that it has happened in the past. After injecting the patient in the right arm patient fainted for roughly about 5 seconds. Paitent woke up and was instructed to lie down and raise feet. Patient was asked if they needed an ambulance called and they refused. Water was given to patient and patient was instructed to stay in store for 20 minutes. After that patient said they felt fine and left with her father.
4/5/11 Tdap. 4/6/11 localized pain decreased ROM of (L) arm.
Red area around flu shot injection site. Approximately 3" by 2". Patient states it is irritated and warm to the touch.
COVID arm rash; slight itching. Yesterday, February 8th, felt like I was fighting a cold. When I went to bed I noticed I felt something but wasn?t sure until I went to the gym. My left shoulder where the injection is located seems a little swollen. I didn?t notice the rash until I took a shower. I have taken pictures and notified my primary care physician
Patient started with headache next day after receiving 1st dose; Chills; Fatigue; bodyaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Patient started with headache next day after receiving 1st dose), CHILLS (Chills), FATIGUE (Fatigue) and MYALGIA (bodyaches) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 036B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced HEADACHE (Patient started with headache next day after receiving 1st dose), CHILLS (Chills), FATIGUE (Fatigue) and MYALGIA (bodyaches). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, HEADACHE (Patient started with headache next day after receiving 1st dose), CHILLS (Chills), FATIGUE (Fatigue) and MYALGIA (bodyaches) outcome was unknown. Not Provided          Concomitant medication include: Thyroid medication
Fever within two hours. Arm sore from the time of the shot. Developed a bruise and swelling and redness. Super tired, a bit light headed (still 72 hours out), but doing activities as "normal." Iced arm for two days on and off and now using heat.  Just wanted to share my experience.
Pt developed DOE one week after first shot.  Symptoms worsened gradually.  He presented to Hospital 01/23/2021 with Saddle Pulmonary Embolus.
Date and time of vaccination: (list both if they received both shots):   1-9-2020 @9:11am   LOT # 011L20A 2-3-2020 @11:00am  LOT # 012M20A  patient states she had a fever of 104F, took tylenol approx 1hr before calling. temp is now 97.9F. advised to contnue to use tylenol as instructed on the label to keep temp at bay. not to use heavy bedding or clothing, to use a light sheet or a cool bath to help with symptoms. informed her if fever does not trend down w/tylenol then to seek care at an urgent care. recommended fluids to stay hydrated.  verbalized understanding. advised if nay life threating change began to call 911. verbalized understanding.
soon p/recv vax devel high temp;mom treated pt w/extra strength APAP for 4 days;pt also devel a painful lump the size of a golf ball @ the inj site;
Patient has big blackish mark surrounding the injection site and has feeling throbbing pain. As per talk on 10/14/2020 @ 2:40PM, Patient is feeling very unusual pain. Recommended to see the doctor.
Case number PHEH2013US009267, is an initial spontaneous report received from a nurse on 23 Apr 2013: This case refers to a 16-years-old male patient. He received only Men A lyophilized component of MENVEO vaccine (batch number: M12024) reconstituted with sterile diluent intramuscularly on 22 Apr 2013. No adverse reaction reported following this administration error.
Information has been received from a 65 year old female consumer with no known allergies or pertinent medical history who on 20-JUL-2007 was vaccinated subcutaneously with a single dose of ZOSTAVAX (lot#656858/0356U). Concomitant therapy included LIPITOR and omeprazole (MSD). On 21-JUL-2007 the patient developed a swollen lump at the injection site which was red, itchy and painful. She states that it seems to get "bigger and bigger". No medical attention was sought. No lab studies were performed. The patient tried DRIXORAL for the symptoms, but it did not seem to help. At the time of this report the patient had not recovered. No other information was provided. There was no product quality complaint involved. Additional information has been requested.
nausea and syncope up tp 30 min after second dose of pfizer COVID vaccine administration discharged on zofran
Itchy papular rash minimally but mostly on chin occurred several hours after vaccination. Rash resolving. On day 2 after immunization, rash resolved.
On unspecified dates, the vaccinee received the series of Engerix-B injections. On an unspecified date post vax, it was determined that the vaccinee "did not respond to the vaccination series". The reporter indicated that 11 adults were immunized, using lots ENG5178A4, ENG3232A4, ENG3382A4 and ENG3374A4. Five of the 11, "did not respond". These 5 individuals (presently unidentified) received the same lots of vaccine as the 6 individuals who did respond.
heartburn; Productive cough; GERD; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Jun-2021 and was forwarded to Moderna on 17-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (heartburn), PRODUCTIVE COUGH (Productive cough) and GASTROOESOPHAGEAL REFLUX DISEASE (GERD) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPEPSIA (heartburn), PRODUCTIVE COUGH (Productive cough) and GASTROOESOPHAGEAL REFLUX DISEASE (GERD). At the time of the report, DYSPEPSIA (heartburn), PRODUCTIVE COUGH (Productive cough) and GASTROOESOPHAGEAL REFLUX DISEASE (GERD) outcome was unknown. Not Provided          No concomitant medications was reported by the reporter.  No treatment medications was provided by the reporter.
she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose; No adverse event; she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    In September 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2022, the patient experienced WRONG PRODUCT ADMINISTERED (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose). On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose).    No concomitant medications was reported.  Dose of Suspect Moderna vaccine was reported as Initial Booster.  No treatment medications was reported.   Reporter did not allow further contact
The patient is 16, and should have received the Pfizer shot, which is approved for 16 and up.  The patient received a Janssen vaccine, which is only approved for 18 and up.